This brief explores Swedish healthcare professionals’ perspectives on access to medical innovation, including new therapies, technologies, and care models. It highlights perceived barriers such as reimbursement processes, regional variation, administrative burden, and system capacity constraints. The document also captures HCP priorities around evidence quality, patient outcomes, and equitable access. IQVIA underscores the importance of aligning clinical evidence, health policy, and system-level planning to improve timely adoption of innovation while maintaining sustainability within Sweden’s healthcare framework.

Join for free to read